Larimar Therapeutics (LRMR) EPS (Basic) (2013 - 2026)
Larimar Therapeutics' (LRMR) quarterly EPS (Basic) came in at -$0.88 in Q4 2025, down 71.76% YoY from -$3.11 in Q4 2024, and down 35.67% on a QoQ basis from -$0.65 in Q3 2025.
Larimar Therapeutics (LRMR) EPS (Basic) (2013 - 2026) Analysis & Trends
Larimar Therapeutics (LRMR) has 13 years of EPS (Basic) data on file, last reported at -$0.88 in Q4 2025.
- Quarterly EPS (Basic) fell 71.76% year-over-year to -$0.88 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.48 (down 27.57% YoY) and the FY2025 annual result came in at -$2.39, up 44.64% from the prior year.
- EPS (Basic) fell to -$0.88 in Q4 2025, from -$0.65 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.22 in Q1 2023 to a low of -$7.75 in Q4 2021.
- A 5-year average of -$1.41 and a median of -$0.6 in 2025 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 85.61% in 2024, down 134.44% in 2024.
- Tracing LRMR's EPS (Basic) over 5 years: stood at -$7.75 in 2021, then rose by 29.28% to -$5.48 in 2022, then soared by 35.23% to -$3.55 in 2023, then jumped by 85.61% to -$0.51 in 2024, then tumbled by 71.76% to -$0.88 in 2025.
- The last three EPS (Basic) figures came in at -$0.88 (Q4 2025), -$0.65 (Q3 2025), and -$0.45 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Larimar Therapeutics | 452.93 Mn | 296.66 Mn | - | -0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.39 |
| Dec 31, 2025 | -0.88 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -0.45 |
| Mar 31, 2025 | -0.58 |
| Dec 31, 2024 | -0.51 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.54 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -3.55 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | -5.48 |
| Sep 30, 2022 | -0.49 |
| Jun 30, 2022 | -0.61 |
| Mar 31, 2022 | -0.95 |
| Dec 31, 2021 | -7.75 |
| Sep 30, 2021 | -1.08 |
| Jun 30, 2021 | -1.37 |